Search
Now showing items 41-50 of 59
Article
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19
| Date Issued:
2021 | Copyright:
open access
Papers presented at events
Prevalence of SARS-Cov2 variants of concern (VOC), in Brazil, in the pandemic peak (2021-2022)
| Date Issued:
2023 | Copyright:
open access
Article
Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS-CoV-2): Challenges to Near-Future Breakthroughs
| Date Issued:
2020 | Copyright:
open access
Papers presented at events
SARS-CoV-2 S1, S2, M & N antigens expressed in Pichia pastoris: Affordable, safe & effective vaccine for developing countries
| Date Issued:
2021 | Copyright:
open access
Papers presented at events
Designing recombinant MVAs as dual-antigen vector vaccines against SARS-CoV-2
| Date Issued:
2021 | Copyright:
open access
Papers presented at events
Development of influenza virus expressing the antigenic portion of SARS-Cov-2 S protein as a vaccine to prevent Covid19 and flu
| Date Issued:
2021 | Copyright:
open access
Papers presented at events
Development of COVID-19 vaccine: the Bio-Manguinhos initiative
| Date Issued:
2021 | Copyright:
open access
Article
Classical and Next-Generation Vaccine Platforms to SARS-CoV-2: Biotechnological Strategies and Genomic Variants
| Date Issued:
2022 | Copyright:
open access
Article
Intranasal Liposomal Formulation of Spike Protein Adjuvanted with CpG Protects and Boosts Heterologous Immunity of hACE2 Transgenic Mice to SARS-CoV-2 Infection
| Date Issued:
2023 | Copyright:
open access
Article
Viral load: We need a new look at an old problem?
| Date Issued:
2023 | Copyright:
restricted access